Catalyst Wire Dossier Catalyst Wire Dossier

Bexxar (tositumomab) with Iodine-131

tositumomab · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bexxar (tositumomab) with Iodine-131, covering 2015-02-05 to 2015-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]

See pricing